Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ticlopidine hydrochloride 250mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Asasantin Retard m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Dipyridamole+aspirin 200mg/25mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
ReoPro 10mg/5mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Abciximab 10mg/5mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Aspirin 75mg soluble tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Aspirin 300mg m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Disprin CV 300mg m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Pump-Hep 20,000units/20mL infusion |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Pump-Hep 10,000units/10mL infusion |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Multiparin 125,000iu/5mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Multiparin 25,000iu/5mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Micropirin 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Caspac XL 162.5mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Aspirin 162.5mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Enprin 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Nu-Seals Cardio 75 e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Caprin 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
postMI 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
postMI 75mg dispersible tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
postMI 300mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Aspirin 75mg e/c tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Nu-Seals Aspirin 75mg e/c tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Aspirin 100mg m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Disprin CV 100mg m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Aspirin 75mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Angettes 75mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Aspirin 75mg dispersible tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Dipyridamole 10mg/2mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Dipyridamole 50mg/5mL oral suspension - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Persantin Retard 200mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Dipyridamole 200mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Modaplate 25mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Modaplate 100mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cerebrovase 100mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Cerebrovase 25mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Multiparin 5000iu/5mL injection vial |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Monoparin 25,000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Monoparin 5000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Monoparin 5000iu/5mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Monoparin 1000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Monoparin 20,000iu/20mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 125,000iu/5mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 25,000iu/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 10,000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 25,000iu/5mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 25,000iu/5mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 5000iu/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 5000iu/5mL injection vial - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 5000iu/5mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Heparin sodium 1000iu/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Isotard 50XL m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Isib 50XL m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Isodur 50XL m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Isodur 25XL m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Isotard 50XL m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Isotard 25XL m/r tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 100mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 60mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 30mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 15mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 10mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 5mg m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 20mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 10mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
MXL 60mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
MXL 30mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 200mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 150mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 120mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 90mg m/r capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Sevredol 50mg tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 50mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Zomorph 60mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Zomorph 30mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 50mg/50mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Rapiject Morphine sulphate 100mg/50mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Rapiject Morphine sulphate 50mg/50mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 100mg/50mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 50mg/50mL prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morcap SR 50mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 75mg rectal tampon |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 50mg rectal tampon |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 35mg rectal tampon |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 20mg/mL oral solution - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Pharma-Ject Morphine sulphate 100mg/50mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Pharma-Ject Morphine sulphate 50mg/50mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Zomorph 200mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Zomorph 100mg m/r capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Paramax sachet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Paramax tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Migravess Forte effervescent tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Migravess effervescent tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Migraleve yellow tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Migraleve pink tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Migraleve Duopack tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Morphine sulphate 100mg rectal tampon |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Sodium valproate 200mg e/c tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epilim Intravenous 400mg injection+diluent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epilim 200mg/5mL syrup |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
Epilim 200mg/5mL s/f liquid |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|